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Dialysis-associated steal syndrome (DASS) is defined as a
clinical condition caused by arterial insufficiency distal to the
dialysis access owing to diversion of blood into the fistula
or graft. The incidence of symptomatic DASS requiring
treatment is 1–8%. The etiology is iatrogenic and symptoms
are quite debilitating. Banding of the access inflow has
largely been abandoned because of the inherent problem
with balancing fistula flow with distal flow complicated by
a high incidence of subsequent access thrombosis. In this
study, we are reporting a modification to the traditional
banding procedure, which markedly improves banding
outcomes. We are reporting 16 patients who underwent a
new standardized minimally invasive banding procedure
performed in an outpatient setting with minimal morbidity.
This modified banding procedure requires a small (1–2 cm)
skin incision for the placement of a ligature and utilizes
a 4 or 5 mm diameter endoluminal balloon to achieve and
standardize the desired reduction of inflow size. All 16
patients had immediate symptomatic and angiographic
improvement after the procedure. Follow-up showed none of
the patients had recurrence of symptoms or thrombosis of
the access. In our experience, this procedure is an excellent
treatment option because of its simplicity and should be
considered as a first-line treatment for patients with DASS.
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Steal is physiologic and occurs in 73% of arteriovenous
fistulas, and 91% of arterio-venous grafts (AVG).1–4 It is
usually asymptomatic not requiring treatment. It seems
physiologic steal is universal, but symptomatic steal occurs in
patients who are unable to develop collateral or direct flow to
offset steal.5,6 Severe symptomatic ischemia is characterized
by hand weakness, rest pain, and tissue necrosis. It requires
treatment in 1% of arteriovenous fistulas and 2.7–4.3% of
AVG,7 although it varies from 1–8% in different studies.1–3
Steal syndrome differs from ischemic neuropathy in the time
of onset (immediate in ischemic neuropathy) and severity of
symptoms (more severe pain and paralysis in ischemic
neuropathy) without clinical evidence of ischemia of the
involved extremity in patients with ischemic neuropathy.
Diagnosis of dialysis-associated steal syndrome (DASS)
requires three criteria to be fulfilled: (1) symptoms highly
suggestive of DASS, (2) absent forearm pulses, and (3) radio-
graphic criteria. Patients with DASS have three radiographic
variations. Most patients have no visualized contrast flowing
into the downstream artery. Some patients will have contrast
flow into the downstream artery which refluxes right back
into the arteriovenous access. Rarely there is a radiographic
wisp of contrast flowing downstream toward the hand, which
takes more than 10 s to reach the palmer arch.
Treatment options include: sacrifice of the access, flow
reduction procedure (banding), percutaneous transluminal
angioplasty (PTA) of arterial stenosis, and various revascu-
larization surgeries as achieved in Distal Revascularization
and Interval Ligation (DRIL),7 and Revision Using Distal
Inflow (RUDI).8 Patients usually have limited options for
new access creation making sacrifice of the access a less than
optimal choice. Historically, banding of the access inflow has
had limitations. If the band is too tight, it causes poor dialysis
efficiency or thrombosis of the access, and if too loose, it
does not alleviate symptoms.7,9–11 PTA of the inflow artery is
a good choice if the cause of steal syndrome is stenosis of the
proximal artery, whereas PTA of the distal artery can improve
flow if focal stenosis is noted angiographically. Revasculari-
zation surgeries are complex and met with various degrees of
success. We have developed an improved and standardized
flow reduction procedure, which is called the ‘MILLER’
(Minimally Invasive Limited Ligation Endoluminal-assisted
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Revision). This technique overcomes the inherent difficulties
of sizing associated with banding. It can be easily and safely
performed in an outpatient setting with good outcomes and
minimal-associated morbidity.
RESULTS
The incidence of DASS requiring treatment in our practice
was 1.33% (approx.). In our study, all patients (100%) had
significant symptomatic improvement. The mean follow-up
is 3 months and the longest follow-up is 11 months. One
patient 6.25% had moderate residual but tolerable symptoms
secondary to severe atherosclerotic arterial disease. Banding
was carried out to 4 mm in 87.5% (14/16) and 5 mm dia-
meter in 12.5% (2/16) of patients. Three patients developed
steal symptoms after they had angioplasty of the venous
outflow for access dysfunction. An immediate complaint of
pain and severe coldness of the hand resulted in the need for
a MILLER procedure before one patient left the angiography
table. The remaining two patients had high suspicion for
developing steal symptoms on angiography but returned after
a few days with symptoms and signs of DASS and had a
MILLER procedure performed. One patient had an arterial
ischemic ulcer with acute tissue necrosis on the dorsum of
the hand. It healed within 1 week following the procedure.
Another patient with fingertip necrosis was banded and
then referred for amputation. Post-amputation healing was
uneventful.
No infections have been reported at the cut down site. No
aneurysms have developed proximal to the ligature. One
hundred percent of the patients have a working access within
the follow-up period. Two patients (12.5%) required some
type of intervention on their access unrelated to a steal
syndrome.
DISCUSSION
Distal ischemia of the access bearing extremity without
angiographic evidence of occlusive arterial lesions defines
true DASS. The hemodynamics of steal follows the principle
of blood flow traveling the path of least resistance. The
instant an access is created physiologic steal is present. It is
usually asymptomatic and does not require treatment. When
resistance in the access becomes significantly less than in the
native arteries, the patient develops symptomatic steal.5,6
Previous studies have identified independent DASS risk
factors such as female gender, diabetes,1,9 and previous access
surgery in the ipsilateral stealing extremity.9
Access creation requires establishing flow equilibrium
between an arteriovenous access and the downstream artery.
If there is an equilibrium shift favoring blood flow to the
downstream artery, patients will have problems with low
blood flows or access thrombosis. If flow is mostly going to
the access, patients will develop steal syndrome. In our
opinion, the angle between the inflow artery, access ana-
stomosis, and downstream artery is an important deter-
minant of preferential blood flow (Figure 1). The overall size
of the arterial anastomosis and relative resistance between the
access and downstream artery are other determinates of
DASS. Many patients develop steal over time as dynamic
forces such as high blood flow, atherosclerosis increasing
resistance in the downstream artery, and endovascular
interventions causing a shift in flow equilibrium.
The greatest determinate of steal appears to be the angle
relationship between the arterial anastomosis, upstream artery,
and downstream artery. The overall size of the anastomosis
may be less important. Although we are not changing the
arterial anastmostic angles with the MILLER procedure, the
resistance created in the access outflow shifts the equilibrium
and diminishes steal symptoms. More studies in the future are
required to help us better understand these observations.
If patients have symptoms of steal and a 4 mm
anastomosis is noted angiographically with adequate angio-
graphic runoff into the downstream artery, then the patients
need to be evaluated for other causes of symptoms such as
peripheral neuropathy. None of our patients with DASS had a
4 mm anastomosis. Moreover, in our practice, we routinely
dilate the arterial anastomosis to 5–6 mm during procedures
such as a routine thrombectomy without development of
steal symptoms.
So far none of our patients have developed aneurysmal
dilatation proximal to the site of banding. We do not expect
any patient to develop aneurysmal dilatation in the future as
no needle cannulation occurs in this very proximal segment
of the access. Pressures are generally low proximally owing to
a small intraluminal radius and low wall tension. Flow also
can readily escape into the downstream artery effectively
decompressing this segment.
Acute angle of downstream 
artery favors graft flow
Upstream 
arteryLarge arterial anastomosis 
favors graft flow
4 mm MILLER band
Graft
Angle favors graft 
flow Downstream 
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Figure 1 | Identifies two of the main flow characteristics that we
believe are the major determinates of DASS. Firstly, the arterial
anastamosis is larger than the downstream artery feeding the hand.
This favors graft flow. Secondly, the upstream and downstream
arteries form an acute angle diverting flow preferentially into the
graft. This patient had severe ischemic symptoms until the 4 mm
MILLER ligature was placed.
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DASS is usually associated with the access placed above the
trifurcation of the brachial artery. It is rarely reported with
radiocephalic (Brescia–Cimino) and high radial artery
anastomotic fistulas. In our study, 94% of patients had an
access originating from the brachial artery and only 6%
patients had the access originating from the radial artery.
Initial sensory symptoms of coldness and parasthesias of the
hand are the hallmarks of arterial DASS. Symptoms are
usually mild and do not require intervention as most patients
will improve in few weeks.7 Rest pain, pain or intolerable
coldness during dialysis, and motor symptoms with hand
weakness or atrophy of the hand muscles are indications for
intervention, hopefully before the development of ulcers or
gangrene of the digits.
The importance of making the diagnosis of true DASS is
critical for the success of the procedure. All three criteria of
diagnosing DASS should be met before undertaking the
procedure. Good contrast flow to the hand when angio-
graphy is performed with outflow access compression (occlu-
ded) has been strong indicator of success with this procedure.
This study is important to rule out any downstream artery
stenosis. Thus far, the presence of mild-to-moderate athero-
sclerotic disease has not prevented success of the procedure.
The aim of treatment is to alleviate DASS symptoms
while retaining arteriovenous access patency. The simplest
treatment for ischemia is ligation of the fistula, thereby
eliminating steal and improving distal perfusion. Even
though symptoms resolve, the patient requires another
access to continue renal replacement therapy. Till now, the
only reportedly reliable option to treat DASS surgically is
either DRIL7 or RUDI. DRIL consists of ligation of the artery
distal to the fistula and placement of a bypass vein graft with
a proximal anastomosis at least 5 cm above the access and a
distal anastomosis immediately below the arterial ligation.
The bypass re-establishes distal perfusion of the hand, and
should maintain adequate flow to the dialysis access. With
RUDI, as name suggests, the fistula is revised using more
distal inflow. DRIL and RUDI are open procedures and carry
the usual surgical and anesthetic risks.
Non-standardized banding was widely used in the past but
has produced disappointing results and has now been largely
abandoned because of poor reliability. Banding reduces the
blood flow through the vascular access by creating a focal
lesion of high resistance (stenosis) within the access circuit,
thus improving distal perfusion. There is a paucity of data on
long-term follow-up after banding. One study describing
long-term follow-up after this technique reported a patency
rate of 62.5% at 6 months and 38.5% at 1 year.12 Another
study using the same technique reported that banding
achieved symptomatic relief in 10 patients; however, it
resulted in thrombosis of the access (arteriovenous fistulas)
with patency rate of 9% at 6 months.5 The main problem is
proper adjustment of the size of the ligature to obtain
sufficient reduction in the blood flow rate while maintaining
the patency of the access. In the MILLER procedure, standard
predictable caliber is achieved by choice of balloon size.
The procedure described here essentially is a modified
version of banding. It improvises on the inherent failure
associated with blind banding. Traditionally, the band is
either too tight (chokes off blood flow in the access) or too
loose to improve the patient’s steal symptoms. In this
procedure, an endoluminal balloon gives the exact desired
inflow size. Sizing is a simple decision based on angiographic
criteria. The only two logical choices are a 4 or 5 mm diameter
band. A 3 mm diameter band would cause too much restric-
tion in access flow and possible thrombosis, and a 6 mm
diameter band would be ineffective in redirecting flow
into the native 3–5 mm diameter forearm arteries. Figure 2
illustrates a surgical ligature, performed blindly which failed
to correct the steal. Also identified in the image is a 4 mm
MILLER ligature which adequately corrected the steal. The
current follow-up for this patient is 11 months with a working
access and elimination of symptoms. In our study, 14 patients
had banding to size 4 mm and two patients to 5 mm size.
A MILLER procedure has the advantage of being signi-
ficantly less invasive than a DRIL procedure. This procedure
can be performed quickly and safely in an outpatient setting.
It is easily reversible using balloon angioplasty technique to
either stretch or break the band if access flow is too slow. It
has a minimal-associated morbidity considering the entire
procedure consists of a small (1–2 cm) skin incision coupled
with a 5F puncture into the access in order to place the
sizing balloon. For these reasons, it seems that the MILLER
procedure is an excellent option for the patient suffering with
this debilitating condition. Although we have demonstrated
short-term success, further follow-up will be critical to
in advocating this procedure before the other surgical
alternatives.
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Figure 2 | A 68-year-old female with right upper arm brachial
artery to cephalic vein fistula presented with DASS. She was
referred to her vascular surgeon who placed a clip proximally
attempting to correct the steal syndrome. The patient then returned
with persistent severe steal symptoms and underwent a MILLER
procedure, which sized the flow restricting band to 4 mm. The patient
had an immediate resolution of symptoms.
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Evaluation of the patients with symptoms of hand
ischemia has been a daunting problem in the past. It is
easier now that we have developed an objective protocol at
our center. Studying the arterial anatomy angiographically
is of primary importance. Understanding the hemodynamics
of the affected limb by a detailed clinical examination
and arteriography is necessary to establish the diagnosis. If
ischemia is owing to arterial insufficiency and focal arterial
stenosis is identified, an endovascular PTA can correct the
steal and improve the perfusion to the downstream artery.
Patients with diffuse severe peripheral arterial disease posess a
significant treatment challenge for which neither endo-
vascular treatment nor surgical revascularization can provide
relief. Treatment should be individualized depending upon
severity of symptoms, availability of another site for access
placement, age of the patient, and comorbid conditions. For
patients with diagnosis of true DASS, in our opinion, the
first option offered to the patient should be a ‘MILLER’
procedure because it is safe, effective, minimally invasive, and
has extremely low associated morbidity.
Our suggested approach to suspected post-access ischemia
is as follows (Algorithm 1):
Conclusion
In our experience, ischemia of the hand associated with
dialysis angioaccess creation is an under-treated problem. All
interventionalists, especially in a high volume dialysis access
practice, will eventually not only see but will also create a steal
syndrome during a routine angioplasty of a venous outflow
stenosis. If we are more vigilant about patient’s symptoms, we
may identify more patients who are suffering with steal
syndrome Given this eventuality, it is important that we have
the skill set necessary to correct steal immediately. Patients
should no longer suffer endless delays to correct a syndrome,
which can be easily corrected with the MILLER procedure.
MATERIALS AND METHODS
This paper presents all of the patients (16) requiring intervention
who presented to our freestanding hemodialysis access care center
with various symptoms associated with DASS from February 2005
to November 2005. All patients underwent physical examination
and angiographic evaluation for objective criteria before being
classified as DASS.
Median age of presentation was 63 years (Table 1) and there were
equal number of men and women in the study. There were 50%
(8/16) Caucasian, 37.5% (6/16) African American, and 12.5% (2/16)
Asians. Coexisting risk factors for vascular disease were hypertension
94% (15/16), diabetes 50% (8/16), and documented coronary artery
disease 37.5% (6/16) of patients. Access distribution was 62.5%
(10/16) autologous fistulas. Ninety-four percent (15/16) patients
had access in the upper extremity and 88% (14/16) of the patients
had access fed by a brachial artery. Only one patient, 6% (1/16), had
an access feeding from the radial artery and remaining one patient,
6% (1/16), is feeding through femoral artery. Two patients (12.5%)
had a forearm graft access originating from the brachial artery below
the elbow. The most common reasons for intervention were numb-
ness, tingling, and severe coldness in the hand (56% (9/16)) and rest
pains (50% (8/16)). Other symptoms were pain during dialysis
(45% (7/16)), weakness (19% (3/16)), tissue necrosis (12.5%
Table 1 | Characteristics of 16 patients with DASS
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Figure 3 | This is a left upper arm brachial artery to cephalic vein
fistula. A catheter is placed into the proximal (upstream) artery and
5 cm3 of contrast are injected over 1 s. Nearly 100% of arterial flow
enters the fistula. No contrast is noted distal to the fistula
anastomosis. This is typical of DASS.
Patient with sign and symptoms suggestive of steal syndrome 
1. Symptoms started soon after surgery 1. Symptoms suggestive of DASS
2. Exam showed no signs of ischemia 2. Absent peripheral pulses Multifactorial 
3. Angiography showed good flow to  3. Radiographic criteria fulfilled
Treat     
accordingly




immediately “MILLER” procedure 
1. Radiologically poor flow distally Lesion identified in proximal artery
2. Vessel atherosclerotic throughout    
3. No single Identifiable lesion  
Stenosis of proximal (feeding) artery
Angioplasty of lesion with resolution 
of symptomsDiagnosis atherosclerotic arterial disease 
Treatment varies
distal artery
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(2/16)), and multiple symptoms in (62.5% (10/16)) patients.
Banding was carried out to 4 mm in 87.5% (14/16) and 5 mm
diameter in 12.5% (2/16) of patients.
Procedure
The basic principle of access flow limiting is to increase the blood
flow to the downstream (see Figures 3 and 4) artery by restricting
flow to the access without compromising access function or patency.
After a detailed physical examination, the diagnosis of DASS is
confirmed angiographically (GE OEC 9800 plus). Access is gained
through the main body of fistula in retrograde manner toward the
arterial inflow. A 0.035 glide wire in conjunction with Berenstein
catheter (4fr) is used to cross the arterial anastomosis. After placing
the catheter in the artery, selective arteriography is performed. If
no contrast flow is visualized beyond the access anastomosis
contrast (loxilan 62%, 300 mg/ml, mfg. Guerbet LLC) flow timing
is performed with access compression to rule out severe athero-
sclerotic disease of the peripheral arteries.
Visualization to the vessel origin may be necessary to exclude
more proximal inflow stenosis and aberrant anatomy. Orthogonal
views are obtained to search for stenosis. If stenosis are present,
appropriate PTA may be effective treatment for the DASS. If no focal
stenosis is present, flow restriction is performed.
The procedure is performed using local anesthesia (1%
xylocaine) and intravenous conscious sedation with Fentanyl
(fentanyl citrate 50 mg/ml, from Hospira, Inc., Lake Forest, IL,
USA) and Versed (Midazolam HCL 2 mg/2 ml, from Hospira, Inc.,
Lake Forest, IL, USA).
Through a small (1–2 cm) incision, the vein (fistula) or graft is
carefully dissected using blunt dissection technique (Figure 5) so
that a 2-0 monofilament ligature (Ethylon or Proline) can be passed
around it (Figure 6). The site of incision is usually within 2–3 cm of
the arterial anastomosis avoiding any problems with dialysis needle
placement. After appropriately sizing the vessels, the procedure
utilizes an endoluminal angioplasty balloon to achieve the desired
(corrected) size of the access inflow. The predicted correct size of the
inflow should be equal to or smaller than the size of the down-
stream artery. The corrected size of the inflow dictates the size of
the balloon chosen for the procedure. An angioplasty balloon
(ultra-thin diamond Balloon from Boston Scientific/Meditech) is
then inflated to 18 atmospheric pressure in the juxta-anastamotic
segment and the ligature is tied snugly around the outside of
the access. The balloon is deflated and patient is evaluated for
symptomatic and angiographic improvement. If the patient reports
no symptomatic improvement and still is ongoing angiographic
evidence of steal, the procedure can be repeated with a second
ligature tied approximately 0.5 cm juxtaposed to the first ligature.
The second suture effectively creates a segment of high resistance
rather than a focal high resistance band. In some cases, an initial
5 mm ligature is downsized to a 4 mm ligature. A 3.5 mm ligature is
a possibility, but has not yet been necessary.
The patient is then re-evaluated for additional intervention.
The incision site is closed with 2.0 nylon sutures and the patient
discharged to recovery for a short period. Subjective symptomatic
improvement is often noted while the patient is still on the table or
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Figure 4 | Patient in Figure 1 post-MILLER procedure. A catheter is
placed into the proximal (upstream) artery and 5 cm3 of contrast are
injected over 1 s. A MILLER ligature is noted at the large arrow.
Contrast can be seen distal to the access anastamosis indicating a
return of perfusion to the hand.
Isolated fistula vein
Figure 5 | Patient with right forearm fistula with isolated vein
through a 1.5 cm incision.
Nylon suture (2.0) passed
around the access
Figure 6 | A nylon suture (2.0) passed around the patients right
forearm fistula vein before tying the MILLER ligature.
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